Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Ozempic is not directly linked to hyperpigmentation or dark spots. The term "Ozempic Face" refers to facial volume loss caused by rapid weight loss—not skin discoloration. However, indirect factors like increased sun sensitivity, nutritional deficiencies from reduced food intake, and post-inflammatory pigment changes may contribute to uneven skin tone in some users.
Below, we cover key contributors to pigmentation shifts during GLP-1 treatment, targeted skincare strategies, and clear signs indicating when to consult a healthcare provider.
If you're noticing skin changes while taking Ozempic and aren't sure whether they're related to the medication, an underlying condition, or something else entirely, don't guess. A free, AI-powered symptom check takes just a few minutes, works instantly online, and can help you understand possible causes and decide on the right next steps—whether that's adjusting your skincare routine or booking a visit with your doctor.
Reviewed for medical accuracy: 07/21/2026
Ozempic (semaglutide) has become a household name in weight management and type 2 diabetes care. Alongside its benefits, questions have emerged about skin changes—especially hyperpigmentation or the so-called "Ozempic Face." This guide breaks down what we know, what remains unproven, and how to care for your skin, with special attention to Ozempic and melasma in Black skin.
These effects lead to weight loss and better glucose levels—but rapid changes can also affect your skin's appearance.
Many describe "Ozempic Face" as a gaunt, hollow, or aged look after losing weight. This is not true hyperpigmentation, but rather:
Key points:
Hyperpigmentation
Uneven darkening of skin from excess melanin. Triggers include sun exposure, inflammation, hormones, or injury.
Melasma
A specific form of hyperpigmentation with brown or gray-brown patches, often on the face. Common triggers:
Melasma is particularly prevalent and often more stubborn in darker skin tones.
At this time, no large clinical studies link Ozempic directly to new or worsening hyperpigmentation or melasma. Here's what current data show:
While Ozempic itself isn't known to trigger melasma, some related factors might play a role:
Sun Sensitivity
• Rapid weight loss can change your body's metabolism, potentially increasing sun sensitivity.
• Unprotected sun exposure worsens all hyperpigmentation.
Nutritional Changes
• Reduced calorie intake may lead to lower levels of vitamins C and E, both vital for skin health.
• Deficiencies can impair skin repair and pigment regulation.
Inflammation or Irritation
• Some people experience mild inflammation at injection sites or skin flares (e.g., eczema).
• Post-inflammatory hyperpigmentation can arise in darker skin after any skin injury or irritation.
Hormonal Fluctuations
• Weight loss can slightly shift hormone levels, but not to the degree seen in pregnancy or hormone therapy.
Even if Ozempic isn't a direct cause of melasma, taking good care of your skin can prevent and manage dark spots:
Sun Protection
Topical Treatments
Gentle Cleansing and Moisturizing
Professional Procedures (if needed)
Nutrition and Supplements
Not every dark spot is harmless. If you notice rapidly changing or irregularly shaped spots, discoloration accompanied by itching, bleeding, or pain, or new systemic symptoms like fever or fatigue, use Ubie's free AI-powered dark spots on skin symptom checker to help determine your next steps. Always follow up with your doctor or dermatologist for a definitive evaluation.
While skin changes are typically mild, Ozempic can cause serious reactions in rare cases. Seek immediate medical attention if you experience:
Always speak to a doctor about any new, severe, or persistent symptoms.
Your journey with Ozempic can bring dramatic health benefits. With mindful sun protection, skin care, and regular medical check-ins, you can manage or prevent hyperpigmentation and keep your skin looking its best. If you have any doubts, speak to a doctor—especially for anything that could be serious or life threatening.
(References)
* Li H, Pan T, Zhang T, Huang S. Dermatological Manifestations of Glucagon-Like Peptide-1 Receptor Agonists: A Scoping Review. J Clin Med. 2024 Mar 22;13(7):1710. doi: 10.3390/jcm13071710. PMID: 38610731; PMCID: PMC11012921.
* Wilding JPH. Efficacy and safety of semaglutide for obesity and type 2 diabetes: a narrative review. J Endocrinol Invest. 2023 Jul;46(7):1345-1355. doi: 10.1007/s40618-023-02082-x. Epub 2023 Apr 13. PMID: 37059944; PMCID: PMC10221360.
* Smits MM, Van Raalte DH. Adverse Events with Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Literature. Front Endocrinol (Lausanne). 2021 Mar 4;12:656205. doi: 10.3389/fendo.2021.656205. PMID: 33746977; PMCID: PMC7970428.
* Donati M, Marra A, Ianno G, Lo Monaco M, Trionfetti D, Scuderi N. Facial changes with weight loss: a comparison of surgical and non-surgical weight loss patients. Aesthetic Plast Surg. 2017 Aug;41(4):795-802. doi: 10.1007/s00266-017-0857-x. Epub 2017 May 10. PMID: 28497259.
* Diao Y, Ma Y, Wu Y, Tang M. Pemphigoid associated with glucagon-like peptide-1 receptor agonists: A case series. Int Immunopharmacol. 2024 Jun;131:111956. doi: 10.1016/j.intimp.2024.111956. Epub 2024 Apr 10. PMID: 38626601.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.